Ethics, pricing and the pharmaceutical industry
Journal of Business Ethics · 1992 · Volume 11 · Issue 8
Abstract
This paper explores the ethical obligations of pharmaceutical companies to charge fair prices for essential medicines. The moral issue at stake here is distributive justice. Rawls' framework is especially germane since it underlines the material benefits everyone deserves as Kantian persons and the need for an egalitarian approach for the distribution of society's essential commodities such as health care. This concern for distributive justice should be a critical factor in the equation of variables used to set prices for pharmaceuticals.
Keywords
Health Care, Economic Growth, Critical Factor, Pharmaceutical Industry, Pharmaceutical Company
Enable JavaScript for citation tools and additional paper interactions.